Don’t believe all you read
February 21, 2002
Enough is enough!
On behalf of the Aspen affiliate of the Susan G. Komen Breast Cancer Foundation, I strongly urge an end to re-analysis of outdated studies on the value and effectiveness of screening mammography (Jan. 24, The New York Times).
The steadily declining breast cancer mortality stems from improved treatment and early detection. Screening mammography, as it is currently done, saves lives.
Women are frustrated by conflicting reports on the value of mammography. Advocates question this incessant repetition. Is it truly motivated by scientific concerns? Or is it fueled by economic concerns? Is it, as one survivor challenged, a tactic to “undervalue women’s health issues”?
The Komen Foundation is willing to help design and fund a new, unbiased risk/benefit study of mammography. In addition, the foundation continues to fund research into promising new imaging technologies and other screening techniques.
Until new techniques are thoroughly tested, approved and widely available, screening mammography will remain the “gold standard” in the early detection of breast cancer.
Recommended Stories For You
The Susan G. Komen Breast Cancer Foundation, therefore, strongly recommends that women continue to make and keep yearly appointments with their health care provider for clinical breast examinations and screening mammograms, not only for their continued good health but also for their peace of mind.
Bonnie Murry, president
Aspen Affiliate, Komen Foundation